These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37334282)

  • 1. Growth response of syndromic versus non-syndromic children born small for gestational age (SGA) to growth hormone therapy: a Belgian study.
    Becker M; Thomas M; Brachet C; Heinrichs C; Dotremont H; De Schepper J; Lysy P; Beckers D;
    Front Endocrinol (Lausanne); 2023; 14():1112938. PubMed ID: 37334282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Height at start, first-year growth response and cause of shortness at birth are major determinants of adult height outcomes of short children born small for gestational age and Silver-Russell syndrome treated with growth hormone: analysis of data from KIGS.
    Ranke MB; Lindberg A;
    Horm Res Paediatr; 2010; 74(4):259-266. PubMed ID: 20431273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth and metabolic effects of long-term recombinant human growth hormone (rhGH) treatment in short children born small for gestational age: GH-RAST study.
    Labarta JI; de Arriba A; Ferrer M; Loranca M; Martos JM; Rodríguez A; Samaniego ML; Sánchez-Cenizo L
    J Pediatr Endocrinol Metab; 2020 Jul; 33(7):923-932. PubMed ID: 32623373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of recombinant human growth hormone treatment in children born small for gestational age with syndromic and non-syndromic short stature].
    Cheng M; Cao BY; Liu M; Su C; Chen JJ; Li XQ; Zhang BB; Shi YT; He ZJ; Gong CX
    Zhonghua Er Ke Za Zhi; 2022 Nov; 60(11):1196-1201. PubMed ID: 36319157
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of 3-year growth hormone treatment and body composition in Polish patients with Silver-Russell syndrome.
    Świąder-Leśniak A; Jurkiewicz D; Kołodziejczyk H; Kozłowska A; Korpysz A; Szalecki M; Chrzanowska K
    Endokrynol Pol; 2023; 74(3):285-293. PubMed ID: 37335065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of children born small for gestational age with short stature who qualify for growth hormone treatment.
    Tamaro G; Pizzul M; Gaeta G; Servello R; Trevisan M; Böhm P; Materassi PMA; Macaluso A; Valentini D; Pellegrin MC; Barbi E; Tornese G
    Ital J Pediatr; 2021 Apr; 47(1):82. PubMed ID: 33794966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of Final Height in Patients Born Small for Gestational Age Treated with Recombinant Growth Hormone.
    Adler E; Lambert AS; Bouvattier C; Thomas-Teinturier C; Rothenbuhler A; de Boissieu P; Linglart A
    Horm Res Paediatr; 2021; 94(1-2):52-62. PubMed ID: 34182561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long-term growth, cost-effectiveness, and glycemic effects of growth hormone therapy on children born small for gestational age over 10 years: a retrospective cohort study.
    Al Khalifah RA; Alhakami A; AlRuthia Y; Al Sarraj HZ; Abulqasim J; Al-Rasheedi A; NurHussen A; Naji A
    J Pediatr Endocrinol Metab; 2022 Nov; 35(11):1357-1368. PubMed ID: 36203313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation.
    Takeda A; Cooper K; Bird A; Baxter L; Frampton GK; Gospodarevskaya E; Welch K; Bryant J
    Health Technol Assess; 2010 Sep; 14(42):1-209, iii-iv. PubMed ID: 20849734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth patterns and outcomes of growth hormone therapy in patients with acrodysostosis.
    Ertl DA; Mantovani G; de Nanclares GP; Elli FM; Pereda A; Pagnano A; Sanchis A; Cueto-Gonzalez AM; Berrade S; León MC; Rothenbuhler A; Audrain C; Berkenou J; Knight N; Dolman K; Gleiss A; Argente J; Linglart A
    J Endocrinol Invest; 2023 Aug; 46(8):1673-1684. PubMed ID: 36749450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
    Binder G; Baur F; Schweizer R; Ranke MB
    J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center.
    Al Shaikh A; Daftardar H; Alghamdi AA; Jamjoom M; Awidah S; Ahmed ME; Soliman AT
    Acta Biomed; 2020 Mar; 91(1):29-40. PubMed ID: 32191651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult height in short children born small for gestational age treated with growth hormone.
    Beisti Ortego A; Fuertes Rodrigo C; Ferrer Lozano M; Labarta Aizpun JI; de Arriba Muñoz A
    Med Clin (Barc); 2020 Apr; 154(8):289-294. PubMed ID: 31427155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum leptin in short children born small for gestational age: relationship with the growth response to growth hormone treatment. The Swedish Study Group for Growth Hormone Treatment.
    Boguszewski M; Dahlgren J; Bjarnason R; Rosberg S; Carlsson LM; Carlsson B; Albertsson-Wikland K
    Eur J Endocrinol; 1997 Oct; 137(4):387-95. PubMed ID: 9368507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog: results of a randomized, dose-response GH trial.
    Lem AJ; van der Kaay DC; de Ridder MA; Bakker-van Waarde WM; van der Hulst FJ; Mulder JC; Noordam C; Odink RJ; Oostdijk W; Schroor EJ; Sulkers EJ; Westerlaken C; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4096-105. PubMed ID: 22904179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in body proportions and body fat content in GH-deficient and non-GH-deficient children during the first year of growth hormone treatment.
    Majcher A; Rumińska M; Witkowska-Sędek E; Paluchowska M; Krajewska M; Artemniak-Wojtowicz D; Pyrżak B
    Anthropol Anz; 2024 Jun; ():. PubMed ID: 38912850
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort.
    Maghnie M; Ranke MB; Geffner ME; Vlachopapadopoulou E; Ibáñez L; Carlsson M; Cutfield W; Rooman R; Gomez R; Wajnrajch MP; Linglart A; Stawerska R; Clayton PE; Darendeliler F; Hokken-Koelega ACS; Horikawa R; Tanaka T; Dörr HG; Albertsson-Wikland K; Polak M; Grimberg A
    J Clin Endocrinol Metab; 2022 Nov; 107(12):3287-3301. PubMed ID: 36102184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.
    Van Pareren Y; Mulder P; Houdijk M; Jansen M; Reeser M; Hokken-Koelega A
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3584-90. PubMed ID: 12915640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Puberty and Pubertal Growth in GH-treated SGA Children: Effects of 2 Years of GnRHa Versus No GnRHa.
    van der Steen M; Lem AJ; van der Kaay DC; Hokken-Koèelega AC
    J Clin Endocrinol Metab; 2016 May; 101(5):2005-12. PubMed ID: 26964733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.